Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Willey

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Journal of Drug Targeting|July 5, 2018
Adjuvant anti-angiogenic therapy enhances chemotherapeutic uptake in a murine model of head and neck cancer<sup>.</sup>Andrew C Prince, Neel G Patel, Lindsay S Moore, et al.
Journal of Neurosurgery|October 20, 2019
Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumorAhmed N Ibrahim, Daisuke Yamashita, Joshua C Anderson, et al.
Neoplasia (New York, N.Y.)|February 15, 2022
Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancerMary Smithson, Regina K Irwin, Gregory Williams, et al.
The Journal of Clinical Investigation|March 15, 2021
N-cadherin upregulation mediates adaptive radioresistance in glioblastomaSatoru Osuka, Dan Zhu, Zhaobin Zhang, et al.
Neuro-Oncology Practice|June 3, 2015
Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experienceGrant M Clark, Andrew M McDonald, Louis B Nabors, et al.
Advances in Radiation Oncology|March 5, 2021
Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint InhibitionRoman L Travis, Samuel R Marcrom, Matthew H Brown, et al.
Practical Radiation Oncology|February 26, 2021
Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance ResultsRichard A Popple, Matthew H Brown, Evan M Thomas, et al.
Clinical and Translational Radiation Oncology|October 6, 2025
No differences in therapeutic efficacy while sparing healthy tissue for orthotopic glioblastoma patient-derived xenografts in context of proton FLASHTaylor L Schanel, Manoj Kumar, Lauren C Nassour-Caswell, et al.
Plos One|January 14, 2012
Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific mannerChristine W Duarte, Christopher D Willey, Degui Zhi, et al.
Oncotarget|April 21, 2017
Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targetsEddy S Yang, Christopher D Willey, Amitkumar Mehta, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Journal of Drug Targeting|July 5, 2018
Adjuvant anti-angiogenic therapy enhances chemotherapeutic uptake in a murine model of head and neck cancer<sup>.</sup>Andrew C Prince, Neel G Patel, Lindsay S Moore, et al.
Journal of Neurosurgery|October 20, 2019
Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumorAhmed N Ibrahim, Daisuke Yamashita, Joshua C Anderson, et al.
Neoplasia (New York, N.Y.)|February 15, 2022
Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancerMary Smithson, Regina K Irwin, Gregory Williams, et al.
The Journal of Clinical Investigation|March 15, 2021
N-cadherin upregulation mediates adaptive radioresistance in glioblastomaSatoru Osuka, Dan Zhu, Zhaobin Zhang, et al.
Neuro-Oncology Practice|June 3, 2015
Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experienceGrant M Clark, Andrew M McDonald, Louis B Nabors, et al.
Advances in Radiation Oncology|March 5, 2021
Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint InhibitionRoman L Travis, Samuel R Marcrom, Matthew H Brown, et al.
Practical Radiation Oncology|February 26, 2021
Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance ResultsRichard A Popple, Matthew H Brown, Evan M Thomas, et al.
Clinical and Translational Radiation Oncology|October 6, 2025
No differences in therapeutic efficacy while sparing healthy tissue for orthotopic glioblastoma patient-derived xenografts in context of proton FLASHTaylor L Schanel, Manoj Kumar, Lauren C Nassour-Caswell, et al.
Plos One|January 14, 2012
Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific mannerChristine W Duarte, Christopher D Willey, Degui Zhi, et al.
Oncotarget|April 21, 2017
Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targetsEddy S Yang, Christopher D Willey, Amitkumar Mehta, et al.
Pageof 12